CEACAM7 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-17026
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Format
Concentration
Product Specifications
Immunogen
Clonality
Host
Isotype
Scientific Data Images for CEACAM7 Antibody - BSA Free
Immunohistochemistry-Paraffin: CEACAM7 Antibody [NBP3-17026]
Immunohistochemistry-Paraffin: CEACAM7 Antibody [NBP3-17026] - Staining of human duodenum shows low expression as expected.Immunohistochemistry-Paraffin: CEACAM7 Antibody [NBP3-17026]
Immunohistochemistry-Paraffin: CEACAM7 Antibody [NBP3-17026] - Analysis in human rectum and duodenum tissues using Anti-CEACAM7 antibody. Corresponding CEACAM7 RNA-seq data are presented for the same tissues.Immunohistochemistry-Paraffin: CEACAM7 Antibody [NBP3-17026]
Immunohistochemistry-Paraffin: CEACAM7 Antibody [NBP3-17026] - Staining of human rectum shows high expression.Applications for CEACAM7 Antibody - BSA Free
Immunohistochemistry
Immunohistochemistry-Paraffin
Formulation, Preparation, and Storage
Purification
Formulation
Format
Preservative
Concentration
Shipping
Stability & Storage
Background: CEACAM-7
CEACAM-7 (carcinoembryonic antigen cell adhesion molecule 7; also CGM2) is a 40 - 45 kDa member of the CEACAM subfamily of the CEA family of proteins. It has a restricted expression pattern, being found on epithelium of the colon, appendix and pancreatic ducts. CEACAM-7 is markedly down-regulated in colon carcinoma. Mature human CEACAM-7 is a 209 amino acid (aa), GPI-linked glycoprotein. It contains one V-type (aa 36 - 142) and one C2-type (aa 146 - 233) Ig-like domain, plus a 21 aa C-terminal propeptide. One alternate splice form of CEACAM-7 exists that shows a deletion of aa 143 - 235. No definitive rodent CEACAM-7 has been reported.
Long Name
Alternate Names
Gene Symbol
Additional CEACAM-7 Products
Product Documents for CEACAM7 Antibody - BSA Free
Product Specific Notices for CEACAM7 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.